{"organizations": [], "uuid": "f4fe926877db4176b556caca404a5078669e4cfc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-8895/social", "site_section": "https://www.wsj.com/news/risk-compliance-journal", "section_title": "Risk Management and Regulation Compliance News - Wall Street Journal - Wsj.com", "url": "https://www.wsj.com/articles/executives-fraud-trial-puts-valeant-in-uncomfortable-light-1525188707", "country": "US", "domain_rank": 387, "title": "Executive’s Fraud Trial Puts Valeant in Uncomfortable Light", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-01T19:31:00.000+03:00", "replies_count": 0, "uuid": "f4fe926877db4176b556caca404a5078669e4cfc"}, "author": "Rebecca Davis O’Brien", "url": "https://www.wsj.com/articles/executives-fraud-trial-puts-valeant-in-uncomfortable-light-1525188707", "ord_in_thread": 0, "title": "Executive’s Fraud Trial Puts Valeant in Uncomfortable Light", "locations": [], "entities": {"persons": [{"name": "gary tanner", "sentiment": "none"}, {"name": "andrew davenport", "sentiment": "none"}, {"name": "valeant", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "manhattan", "sentiment": "none"}], "organizations": [{"name": "valeant pharmaceuticals international inc.", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "The fraud trial of a former executive at Valeant Pharmaceuticals International Inc. is set to begin this week in Manhattan federal court, the first criminal prosecution to emerge from multiple investigations into the embattled pharmaceutical giant over its sales practices.\nIn this case, prosecutors say Valeant was the victim. Using a statute often applied to public corruption cases, the U.S. attorney’s office in Manhattan has accused the former Valeant executive, Gary Tanner, and a co-defendant, Andrew Davenport, of defrauding... ", "external_links": [], "published": "2018-05-01T19:31:00.000+03:00", "crawled": "2018-05-01T20:24:41.010+03:00", "highlightTitle": ""}